2023 annual financial data
Kymera Therapeutics 2023 Operating margin
Direct answer
Operating margin was -210.62%.
Operating income was -165,530,000 USD and net income was -146,962,000 USD.
Operating cash flow was -102,826,000 USD.
Get free Kymera Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 78,592,000 USD
- Operating income
- -165,530,000 USD
- Net income
- -146,962,000 USD
- Operating cash flow
- -102,826,000 USD